US2006259247A1PendingUtilityA1
Apparatus and method for automated protein design
Individually held — no corporate assignee on recordPriority: Apr 11, 1997Filed: Jul 21, 2006Published: Nov 16, 2006
Est. expiryApr 11, 2017(expired)· nominal 20-yr term from priority
G16B 15/20G16B 20/00G16B 20/50G16B 30/00C12N 15/1089G16B 15/00C12N 15/1034C07K 14/001C07K 1/00C07K 1/003
64
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to apparatus and methods for quantitative protein design and optimization.
Claims
exact text as granted — not AI-modified1 . A method executed by a computer under the control of a program, said computer including a memory for storing said program, said method comprising the steps of:
(A) receiving a protein backbone structure with variable residue positions; (B) establishing a group of potential rotamers for each of said variable residue positions, wherein at least one variable residue position has rotamers from at least two different amino acid side chains; and (C) analyzing the interaction of each of said rotamers with all or part of the remainder of said protein backbone structure to generate a set of optimized protein sequences, wherein said analyzing step includes a Dead-End Elimination (DEE) computation.
2 . A method executed by a computer under the control of a program, said computer including a memory for storing said program, said method comprising the steps of:
(A) receiving a protein backbone structure with variable residue positions; (B) classifying each variable residue position as either a core, surface or boundary residue; (C) establishing a group of potential rotamers for each of said variable residue positions, wherein at least one variable residue position has rotamers from at least two different amino acid side chains; and (D) analyzing the interaction of each of said rotamers with all or part of the remainder of said protein to generate a set of optimized protein sequences.
3 . A method according to claim 2 wherein said analyzing step comprises a DEE computation.
4 . A method according to claim 1 or 2 wherein said set of optimized protein sequences comprises the globally optimal protein sequence.
5 . A method according to claim 1 or 3 wherein said DEE computation is selected from the group consisting of original DEE and Goldstein DEE.
6 . A method according to claim 1 or 2 wherein said analyzing step includes the use of at least one scoring function.
7 . A method according to claim 6 wherein said scoring function is selected from the group consisting of a Van der Waals potential scoring function, a hydrogen bond potential scoring function, an atomic solvation scoring function, an electrostatic scoring function and a secondary structure propensity scoring function.
8 . A method according to claim 6 wherein said analyzing step includes the use of at least two scoring functions.
9 . A method according to claim 6 wherein said analyzing step includes the use of at least three scoring functions.
10 . A method according to claim 6 wherein said analyzing step includes the use of at least four scoring functions.
11 . A method according to claim 6 wherein said atomic solvation scoring function includes a scaling factor that compensates for over-counting.
12 . A method according to claim 1 or 2 further comprising testing at least one member of said set to produce experimental results.
13 . A method according to claim 4 further comprising
(D) generating a rank ordered list of additional optimal sequences from said globally optimal protein sequence.
14 . A method according to claim 13 wherein said generating includes the use of a Monte Carlo search.
15 . A method according to claim 2 wherein said analyzing step step comprises a Monte Carlo computation.
16 . A method according to claim 13 further comprising:
(E) testing some or all of said protein sequences from said ordered list to produce potential energy test results.
17 . A method according to claim 16 further comprising:
(F) analyzing the correspondence between said potential energy test results and theoretical potential energy data.
18 . A method according to claim 1 or 2 further comprising altering at least one supersecondary structure parameter value of said protein backbone structure prior to establishing said potential rotamer group.
19 . An optimized protein sequence generated by the method of claim 1 or 2 .
20 . A nucleic acid sequence encoding a protein sequence according to claim 19 .
21 . An expression vector comprising the nucleic acid of claim 20 .
22 . A host cell comprising the nucleic acid of claim 20 .
23 . A protein having a sequence that is at least about 5% different from a known protein sequence and is at least 20% more stable than the known protein sequence.
24 . A computer readable memory to direct a computer to function in a specified manner, comprising:
a side chain module to correlate a group of potential rotamers for residue positions of a protein backbone model; a ranking module to analyze the interaction of each of said rotamers with all or part of the remainder of said protein to generate a set of optimized protein sequences.
25 . A computer readable memory according to claim 24 wherein said ranking module includes a van der Waals scoring function component.
26 . A computer readable memory according to claim 24 wherein said ranking module includes an atomic solvation scoring function component.
27 . A computer readable memory according to claim 24 wherein said ranking module includes a hydrogen bond scoring function component.
28 . A computer readable memory according to claim 24 wherein said ranking module includes a secondary structure scoring function component.
29 . A computer readable memory according to claim 24 further comprising
an assessment module to assess the correspondence between potential energy test results and theoretical potential energy data.Join the waitlist — get patent alerts
Track US2006259247A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.